After-Hours Biotech Gainers: TNON, BIVI, EDSA, RNAZ, HCWB

After-hours gainers highlighted include Tenon Medical, which reported Q2 results and implemented a reverse stock split, alongside BioVie and Edesa Biotech advancing pipeline development (a Parkinson’s drug and EB06, respectively). The update is largely informational with limited quantitative detail, implying a modest read-through rather than a broad repricing catalyst.

Analysis

After-hours gainers highlighted include Tenon Medical, which reported Q2 results and implemented a reverse stock split, alongside BioVie and Edesa Biotech advancing pipeline development (a Parkinson’s drug and EB06, respectively). The update is largely informational with limited quantitative detail, implying a modest read-through rather than a broad repricing catalyst.